Responses
Epidemiology and outcomes
Original research
Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA
Compose a Response to This Article
Other responses
No responses have been published for this article.